Quinolyl amide derivatives as CCR5 antagonists

被引：0
|
作者：
Lu, Shou-Fu [1 ]
Dunning, Laura [1 ]
Jaroch, Stefan [1 ]
Kirkland, Thomas [1 ]
Onuffer, James [1 ]
Phillips, Gary [1 ]
Subramanyam, Babu [1 ]
Tseng, Jih-Lie [1 ]
Wei, Ming [1 ]
Ye, Hong [1 ]
Ye, Bin [1 ]
机构：
[1] Berlex Biosci, Richmond, CA 94804 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
67-MEDI
引用
收藏
页码：838 / 838
页数：1
相关论文
共 50 条
  • [31] CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1
    Bredeek, U. Fritz
    Harbour, Michael J.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 427 - 434
  • [32] Discovery of CCR5 antagonists containing the aminoguanidine group.
    Kesicki, EA
    Odingo, JO
    Oliver, AR
    Orme, MW
    Schweickart, VL
    Epp, A
    Gray, PW
    Fowler, KW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U19 - U19
  • [33] Advances of CCR5 antagonists: From small molecules to macromolecules
    Qi, Baowen
    Fang, Qiang
    Liu, Shiyuan
    Hou, Wenli
    Li, Jian
    Huang, Yingchun
    Shi, Jianyou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [34] The discovery of tropane-derived CCR5 receptor antagonists
    Armour, DR
    de Groot, MJ
    Price, DA
    Stammen, BLC
    Wood, A
    Perros, M
    Burt, C
    CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (04) : 305 - 308
  • [35] Allosteric effects of antagonists on signalling by the chemokine receptor CCR5
    Haworth, Ben
    Lin, Hong
    Fidock, Mark
    Dorr, Pat
    Strange, Philip G.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (06) : 891 - 897
  • [36] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
    Miller, MD
    Lineberger, JE
    Dornadula, G
    Danzeisen, RC
    Blau, CR
    Danovich, RM
    Miller, MA
    Finke, PE
    Oates, BD
    Caldwell, CG
    Chen, P
    Meurer, LC
    Mills, SG
    Springer, MS
    Petropoulos, CJ
    Whitcomb, J
    Huang, W
    Fransen, S
    Simon, AJ
    Hazuda, DJ
    ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
  • [37] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    AIDS, 2008, 22 (16) : 2212 - 2214
  • [38] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [39] Synthesis of 1-benzothiepine and 1-benzazepine derivatives as orally active CCR5 antagonists
    Aramaki, Y
    Seto, M
    Okawa, T
    Oda, T
    Kanzaki, N
    Shiraishi, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (02) : 254 - 258
  • [40] Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists
    Hu, Suwen
    Wang, Zhilong
    Hou, Tingjun
    Ma, Xiaodong
    Li, Jing
    Liu, Tao
    Xie, Xin
    Hu, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) : 1157 - 1168
12345